Developing a General Population Screening Programme for Paediatric Type 1 Diabetes: Evidence from a Qualitative Study

Lauren M Quinn1, Parth Narendran1,2, Kirandeep Bhavra3

  • 1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.

Pediatric Diabetes
|April 30, 2025
PubMed

Insights

Parental involvement in the UK's new type 1 diabetes (T1D) screening program for children (ages 3-13) is key. Clear communication on benefits, less invasive tests, and support systems are crucial for successful implementation.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Screening
  • Qualitative Research Methods

Background:

  • The UK has launched a prototype population-based screening program for type 1 diabetes (T1D) in children aged 3-13.
  • Reliable tests and preventative treatments for T1D are now available.
  • Understanding parental perspectives is vital for the ethical and sustainable implementation of this screening program.

Purpose of the Study:

  • To explore parental views on the UK's new pediatric type 1 diabetes screening program.
  • To identify factors that encourage and support parental involvement in the screening process.

Main Methods:

  • Qualitative interviews were conducted with 38 parents.
  • Data analysis utilized a "Burden of Screening" framework with three domains: pre-screening tasks, engagement factors, and consequences of participation.

Main Results:

  • Parents emphasized the need for clear communication regarding T1D screening benefits to address anxiety.
  • Preferences included less invasive testing, structured healthcare professional support, and peer support.
  • Concerns were raised about potential overprotective behaviors and anxiety following a positive screening result.

Conclusions:

  • Clear communication of T1D screening benefits is essential to improve uptake.
  • Decision-support tools and targeted educational materials should be developed.
  • Post-testing, parents desire peer support and psychological counseling access.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
805
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
471
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
204
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
943